Evidence map›Paper›PMID 37956904›Full record

ArticleJournal of vascular surgery. Venous and lymphatic disorders2024

Effect of junctional reflux on the venous clinical severity score in patients with insufficiency of the great saphenous vein (JURY study).

Chandu Vemuri, Kathleen D Gibson, Peter J Pappas, Mikel Sadek, Windsor Ting, Andrea T Obi, Nicolas J Mouawad, Yana Etkin, Antonios P Gasparis, Tara McDonald and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of vascular surgery. Venous and lymphatic disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. The verdict is reached in the JURY study!Journal of vascular surgery. Venous and lymphatic disorders · 2024
    Article
  3. Society resources can provide unmet need for real-world data.Journal of vascular surgery. Venous and lymphatic disorders · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Chandu VemuriDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Kathleen D GibsonDepartment of Surgery, Lake Washington Vascular Surgeons, Bellevue, WA.
Peter J PappasDepartment of Surgery, Center for Vein Restoration, Morristown, NJ.
Mikel SadekDepartment of Surgery, NYU Langone Health, New York, NY.
Windsor TingDepartment of Surgery, Mount Sinai, New York, NY.
Andrea T ObiDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Nicolas J MouawadDepartment of Surgery, McLaren Health System, Grand Blanc, MI.
Yana EtkinDepartment of Surgery, Zucker School of Medicine at Hofstra/Northwell, Uniondale, NY.
Antonios P GasparisDepartment of Surgery, Stony Brook Medicine, Stony Brook, NY.
Tara McDonaldDepartment of Surgery, University of Maryland, Baltimore, MD.
Shalini SahooDepartment of Surgery, University of Maryland, Baltimore, MD.
John D SorkinDepartment of Medicine, University of Maryland, Baltimore, MD.
Brajesh K LalDepartment of Surgery, University of Maryland, Baltimore, MD. Electronic address: blal@som.umaryland.edu.
University of Maryland, Baltimore · USUniversity of Michigan · USBellevue Hospital Center · USHofstra University · USMcLaren Health Care · USNYU Langone Health · USStony Brook Medicine · US

Funding

CREST-2 Clinical Coordinating CenterU01NS080168 · NINDS · MAYO CLINIC JACKSONVILLE · PI Thomas G Brott, JAMES F MESCHIA · 2014 to 2026
$56.3M
University of Maryland Claude D. Pepper Older Americans Independence Center (UM-OAIC)P30AG028747 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI ALICE S. RYAN · 2006 to 2026
$28.9M
Healthy Aging Neighborhoods of Diversity Across LifespanZ01AG000513 · NIA · NATIONAL INSTITUTE ON AGING · PI EVANS, MICHELE K · 2001 to 2008
$6.8M
Carotid Revascularization and Medical Management for Asymptomatic CarotidStenosis Trial - Hemodynamics (CREST-H)R01NS097876 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI RONALD M LAZAR, DAVID SIGMUND LIEBESKIND · 2017 to 2026
$6.4M
Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates - 2I01CX001621 · VA · BALTIMORE VA MEDICAL CENTER · PI LAL, BRAJESH K · 2017 to 2021
–
Role of a Novel Exercise Program to Prevent Post-thrombotic SyndromeI01RX000995 · VA · BALTIMORE VA MEDICAL CENTER · PI LAL, BRAJESH K · 2015 to 2020
–
CSRD VA I01 CX001621Intramural NIH HHS Z01 AG000513NIA NIH HHS P30 AG028747NINDS NIH HHS R01 NS097876NINDS NIH HHS U01 NS080168RRD VA I01 RX000995
6 · The paper itself

Abstract

objectiveEffective treatment options are available for chronic venous insufficiency associated with superficial venous reflux. Although many patients with C2 and C3 disease based on the CEAP (Clinical-Etiological-Anatomical-Pathophysiological) classification have combined great saphenous vein (GSV) and saphenofemoral junction (SFJ) reflux, some may not have concomitant SFJ reflux. Several payors have determined that symptom severity in patients without SFJ reflux does not warrant treatment. In patients planned for venous ablation, we tested whether Venous Clinical Severity Scores (VCSS) are equivalent in those with GSV reflux alone compared with those with both GSV and SFJ reflux.

methodsThis cross-sectional study was conducted at 10 centers. Inclusion criteria were: candidate for endovenous ablation as determined by treating physician; 18 to 80 years of age; GSV reflux with or without SFJ reflux on ultrasound; and C2 or C3 disease. Exclusion criteria were prior deep vein thrombosis; prior vein ablation on the index limb; ilio-caval obstruction; and renal, hepatic, or heart failure requiring prior hospitalization. An a priori sample size was calculated. We used multiple linear regression (adjusted for patient characteristics) to compare differences in VCSS scores of the two groups at baseline, and to test whether scores were equivalent using a priori equivalence boundaries of +1 and -1. In secondary analyses, we tested differences in VCSS scores in patients with C2 and C3 disease separately.

resultsA total of 352 patients were enrolled; 64.2% (n = 226) had SFJ reflux, and 35.8% (n = 126) did not. The two groups did not differ by major clinical characteristics. The mean age of the cohort was 53.9 ± 14.3 years; women comprised 74.2%; White patients 85.8%; and body mass index was 27.8 ± 6.1 kg/m

conclusionsSymptom severity is equivalent in patients with GSV reflux with or without SFJ reflux. The absence of SFJ reflux alone should not determine the treatment paradigm in patients with symptomatic chronic venous insufficiency. Patients with GSV reflux who meet clinical criteria for treatment should have equivalent treatment regardless of whether or not they have SFJ reflux.

Indexed as

Varicose VeinsVenous InsufficiencyAdultAgedCross-Sectional StudiesFemaleFemoral VeinHumansMaleMiddle AgedSaphenous VeinTreatment OutcomeAblationGreat saphenous veinRefluxSaphenofemoral junctionVenous

Identifiers

PMID37956904
PMCPMC10939725
OpenAlexW4388599917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.